{"filing":{"accession_number":"0001793229-26-000056","cik":"0001793229","ticker":"CTEV","company_name":"Claritev Corp","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"ctev-20260622.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1793229/000179322926000056/ctev-20260622.htm"},"events":[{"id":12717,"run_id":11285,"accession_number":"0001793229-26-000056","anchor_item_number":"7.01","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"summary":"The disclosure reports closure of a DOJ Antitrust Division grand jury investigation into health insurance practices, with the Company cleared of criminal investigation, but simultaneously reveals an ongoing civil investigative demand from the same division. This is a material legal/regulatory event involving government investigation that does not fit a specific named category (not litigation, not a settlement, not a covenant breach). The dual nature—closure of criminal inquiry but continuation of civil investigation—represents a significant regulatory development affecting the Company's legal exposure and business operations in healthcare.","company_name":"Claritev Corp","ticker":"CTEV","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9648,"accession_number":"0001793229-26-000056","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"reasoning":"The disclosure reports closure of a DOJ Antitrust Division grand jury investigation into health insurance practices, with the Company cleared of criminal investigation, but simultaneously reveals an ongoing civil investigative demand from the same division. This is a material legal/regulatory event involving government investigation that does not fit a specific named category (not litigation, not a settlement, not a covenant breach). The dual nature—closure of criminal inquiry but continuation of civil investigation—represents a significant regulatory development affecting the Company's legal exposure and business operations in healthcare.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:46:55.683245+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9648,"accession_number":"0001793229-26-000056","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"reasoning":"The disclosure reports closure of a DOJ Antitrust Division grand jury investigation into health insurance practices, with the Company cleared of criminal investigation, but simultaneously reveals an ongoing civil investigative demand from the same division. This is a material legal/regulatory event involving government investigation that does not fit a specific named category (not litigation, not a settlement, not a covenant breach). The dual nature—closure of criminal inquiry but continuation of civil investigation—represents a significant regulatory development affecting the Company's legal exposure and business operations in healthcare.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:46:55.683245+00:00","company_name":"Claritev Corp","ticker":"CTEV","filing_date":"2026-06-22"}]}